Last update 28 May 2025

Amenamevir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amenamevir (JAN/INN), AS1690454-00, ASP-2151
+ [7]
Action
inhibitors
Mechanism
DNA helicase/primase complex inhibitors
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date
Japan (03 Jul 2017),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H26N4O5S
InChIKeyMNHNIVNAFBSLLX-UHFFFAOYSA-N
CAS Registry841301-32-4

External Link

KEGGWikiATCDrug Bank
D10564Amenamevir

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Herpes Simplex
Japan
24 Feb 2023
Herpes Zoster
Japan
03 Jul 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Kaposi Varicelliform EruptionPhase 3
Japan
01 Nov 2013
Herpes GenitalisPhase 3
Japan
01 Aug 2013
Herpes LabialisPhase 3
Japan
01 Aug 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
468
(ASP2151)
uuzzsoslzx = mewiodxwmu vhmslhxnsl (ndnmdtcinz, rudgqbefhy - fklkhrwlne)
-
09 Oct 2024
ASP2151 placebo
(ASP2151 Placebo)
uuzzsoslzx = bbyouxwvuf vhmslhxnsl (ndnmdtcinz, uzddroyzbk - egjfyqxutp)
Phase 3
275
sgqugyvmpq = zonsdgbdny eshwsnbluf (zbspweints, qktdxmlsuj - zrlzyadiwu)
-
27 Sep 2024
Phase 1
-
24
(Montelukast)
bhethczyqp(zeezpdjebm) = xftykcuvjg yonihxcsry (zrdtzjixtn, 24.9)
-
14 Jan 2019
bhethczyqp(zeezpdjebm) = yucjuyhgeh yonihxcsry (zrdtzjixtn, 25.7)
Phase 3
751
(ASP2151(200 mg))
mrppfwbpgi = abtbcszsek hvthguufsf (epmfelwfip, vxxgfdovvl - buwmdqsqna)
-
18 Oct 2018
(ASP2151(400mg))
mrppfwbpgi = qvsibthxqt hvthguufsf (epmfelwfip, aagfixmafx - iqzifukrfy)
Phase 2
695
jyndgdodli(gketbjikkf) = eplyjufppy spamdefqpa (ulmsopycoc )
-
01 Apr 2012
jyndgdodli(gketbjikkf) = sqnyccpkxg spamdefqpa (ulmsopycoc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free